INVEX Therapeutics Ltd Cash Flow Quality Index
INVEX Therapeutics Ltd cash flow quality index. INVEX Therapeutics Ltd (IXC) has a Cash Flow Quality Index of -0.27x as of June 2024. Operating cash flow of AU$-126.75K is below net income of AU$470.89K, suggesting accrual-heavy earnings not yet converted to cash. See INVEX Therapeutics Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
INVEX Therapeutics Ltd Cash Flow Quality Index by Year (None–None)
INVEX Therapeutics Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for INVEX Therapeutics Ltd. For the full cash flow conversion analysis, see how efficiently does INVEX Therapeutics Ltd generate cash.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|